STOCK TITAN

[Form 3] Accelerate Diagnostics, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Gilbert E. Nathan has filed a Form 3 (Initial Statement of Beneficial Ownership) following his appointment as Director at Accelerate Diagnostics (AXDX). The filing, dated June 28, 2025, discloses Nathan's beneficial ownership position as of April 10, 2025.

Key details from the filing:

  • Nathan currently holds no securities (derivative or non-derivative) beneficially owned in the company
  • The filing confirms his position as Director but indicates no other roles such as Officer or 10% Owner
  • This is an individual filing, not a joint/group submission
  • Business address is listed as 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

This Form 3 filing is a standard regulatory requirement for new directors under Section 16(a) of the Securities Exchange Act of 1934, establishing a baseline for future ownership reporting.

Gilbert E. Nathan ha presentato un Modulo 3 (Dichiarazione Iniziale di Proprietà Beneficiaria) in seguito alla sua nomina a Direttore presso Accelerate Diagnostics (AXDX). La comunicazione, datata 28 giugno 2025, rivela la posizione di proprietà beneficiaria di Nathan al 10 aprile 2025.

Dettagli principali della dichiarazione:

  • Nathan attualmente non detiene alcun titolo (derivato o non derivato) di proprietà beneficiaria nella società
  • La comunicazione conferma la sua posizione di Direttore senza indicare altri ruoli come Dirigente o Proprietario del 10%
  • Si tratta di una dichiarazione individuale, non congiunta o di gruppo
  • L'indirizzo aziendale è indicato come 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

La presentazione del Modulo 3 è un requisito regolamentare standard per i nuovi direttori ai sensi della Sezione 16(a) del Securities Exchange Act del 1934, stabilendo una base per le future dichiarazioni di proprietà.

Gilbert E. Nathan ha presentado un Formulario 3 (Declaración Inicial de Propiedad Beneficiaria) tras su nombramiento como Director en Accelerate Diagnostics (AXDX). La presentación, fechada el 28 de junio de 2025, revela la posición de propiedad beneficiaria de Nathan al 10 de abril de 2025.

Detalles clave de la presentación:

  • Nathan actualmente no posee ningún valor (derivado o no derivado) de propiedad beneficiaria en la empresa
  • La presentación confirma su cargo como Director pero no indica otros roles como Oficial o propietario del 10%
  • Esta es una presentación individual, no conjunta o grupal
  • La dirección comercial se lista como 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

Este Formulario 3 es un requisito regulatorio estándar para nuevos directores según la Sección 16(a) de la Ley de Intercambio de Valores de 1934, estableciendo una base para futuros reportes de propiedad.

길버트 E. 네이선Accelerate Diagnostics (AXDX)의 이사로 임명된 후 초기 소유권 신고서인 Form 3을 제출했습니다. 2025년 6월 28일자 제출서에는 2025년 4월 10일 기준 네이선의 실소유권 현황이 공개되어 있습니다.

제출서의 주요 내용:

  • 네이선은 현재 회사의 어떠한 증권도(파생상품 포함) 실소유하고 있지 않습니다
  • 제출서는 그의 이사 직위를 확인하지만 임원 또는 10% 이상 소유자 등의 다른 직책은 명시하지 않습니다
  • 개인 제출서이며 공동 또는 그룹 제출이 아닙니다
  • 사업장 주소는 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714로 기재되어 있습니다

이 Form 3 제출은 1934년 증권거래법 16(a)조에 따른 신규 이사에 대한 표준 규제 요건으로, 향후 소유권 보고의 기준을 마련합니다.

Gilbert E. Nathan a déposé un Formulaire 3 (Déclaration Initiale de Détention Bénéficiaire) suite à sa nomination en tant que Directeur chez Accelerate Diagnostics (AXDX). Le dépôt, daté du 28 juin 2025, révèle la position de détention bénéficiaire de Nathan au 10 avril 2025.

Points clés du dépôt :

  • Nathan ne détient actuellement aucun titre (dérivé ou non) en propriété bénéficiaire dans l'entreprise
  • Le dépôt confirme sa fonction de Directeur sans indiquer d'autres rôles tels que Dirigeant ou Propriétaire à 10%
  • Il s'agit d'une déclaration individuelle, non conjointe ou de groupe
  • L'adresse professionnelle est indiquée comme 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

Ce dépôt du Formulaire 3 est une exigence réglementaire standard pour les nouveaux directeurs selon la Section 16(a) du Securities Exchange Act de 1934, établissant une base pour les rapports futurs de détention.

Gilbert E. Nathan hat ein Formular 3 (Erstmitteilung des wirtschaftlichen Eigentums) nach seiner Ernennung zum Direktor bei Accelerate Diagnostics (AXDX) eingereicht. Die Einreichung vom 28. Juni 2025 gibt Nathans wirtschaftliche Eigentumsposition zum 10. April 2025 bekannt.

Wichtige Details der Einreichung:

  • Nathan besitzt derzeit keine Wertpapiere (abgeleitet oder nicht abgeleitet) wirtschaftlich im Unternehmen
  • Die Einreichung bestätigt seine Position als Direktor, weist jedoch keine weiteren Rollen wie Offizier oder 10%-Eigentümer aus
  • Dies ist eine individuelle Einreichung, keine gemeinsame oder Gruppenmeldung
  • Die Geschäftsadresse lautet 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

Das Formular 3 ist eine standardmäßige regulatorische Anforderung für neue Direktoren gemäß Abschnitt 16(a) des Securities Exchange Act von 1934 und legt eine Basis für zukünftige Eigentumsberichte fest.

Positive
  • None.
Negative
  • None.

Gilbert E. Nathan ha presentato un Modulo 3 (Dichiarazione Iniziale di Proprietà Beneficiaria) in seguito alla sua nomina a Direttore presso Accelerate Diagnostics (AXDX). La comunicazione, datata 28 giugno 2025, rivela la posizione di proprietà beneficiaria di Nathan al 10 aprile 2025.

Dettagli principali della dichiarazione:

  • Nathan attualmente non detiene alcun titolo (derivato o non derivato) di proprietà beneficiaria nella società
  • La comunicazione conferma la sua posizione di Direttore senza indicare altri ruoli come Dirigente o Proprietario del 10%
  • Si tratta di una dichiarazione individuale, non congiunta o di gruppo
  • L'indirizzo aziendale è indicato come 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

La presentazione del Modulo 3 è un requisito regolamentare standard per i nuovi direttori ai sensi della Sezione 16(a) del Securities Exchange Act del 1934, stabilendo una base per le future dichiarazioni di proprietà.

Gilbert E. Nathan ha presentado un Formulario 3 (Declaración Inicial de Propiedad Beneficiaria) tras su nombramiento como Director en Accelerate Diagnostics (AXDX). La presentación, fechada el 28 de junio de 2025, revela la posición de propiedad beneficiaria de Nathan al 10 de abril de 2025.

Detalles clave de la presentación:

  • Nathan actualmente no posee ningún valor (derivado o no derivado) de propiedad beneficiaria en la empresa
  • La presentación confirma su cargo como Director pero no indica otros roles como Oficial o propietario del 10%
  • Esta es una presentación individual, no conjunta o grupal
  • La dirección comercial se lista como 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

Este Formulario 3 es un requisito regulatorio estándar para nuevos directores según la Sección 16(a) de la Ley de Intercambio de Valores de 1934, estableciendo una base para futuros reportes de propiedad.

길버트 E. 네이선Accelerate Diagnostics (AXDX)의 이사로 임명된 후 초기 소유권 신고서인 Form 3을 제출했습니다. 2025년 6월 28일자 제출서에는 2025년 4월 10일 기준 네이선의 실소유권 현황이 공개되어 있습니다.

제출서의 주요 내용:

  • 네이선은 현재 회사의 어떠한 증권도(파생상품 포함) 실소유하고 있지 않습니다
  • 제출서는 그의 이사 직위를 확인하지만 임원 또는 10% 이상 소유자 등의 다른 직책은 명시하지 않습니다
  • 개인 제출서이며 공동 또는 그룹 제출이 아닙니다
  • 사업장 주소는 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714로 기재되어 있습니다

이 Form 3 제출은 1934년 증권거래법 16(a)조에 따른 신규 이사에 대한 표준 규제 요건으로, 향후 소유권 보고의 기준을 마련합니다.

Gilbert E. Nathan a déposé un Formulaire 3 (Déclaration Initiale de Détention Bénéficiaire) suite à sa nomination en tant que Directeur chez Accelerate Diagnostics (AXDX). Le dépôt, daté du 28 juin 2025, révèle la position de détention bénéficiaire de Nathan au 10 avril 2025.

Points clés du dépôt :

  • Nathan ne détient actuellement aucun titre (dérivé ou non) en propriété bénéficiaire dans l'entreprise
  • Le dépôt confirme sa fonction de Directeur sans indiquer d'autres rôles tels que Dirigeant ou Propriétaire à 10%
  • Il s'agit d'une déclaration individuelle, non conjointe ou de groupe
  • L'adresse professionnelle est indiquée comme 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

Ce dépôt du Formulaire 3 est une exigence réglementaire standard pour les nouveaux directeurs selon la Section 16(a) du Securities Exchange Act de 1934, établissant une base pour les rapports futurs de détention.

Gilbert E. Nathan hat ein Formular 3 (Erstmitteilung des wirtschaftlichen Eigentums) nach seiner Ernennung zum Direktor bei Accelerate Diagnostics (AXDX) eingereicht. Die Einreichung vom 28. Juni 2025 gibt Nathans wirtschaftliche Eigentumsposition zum 10. April 2025 bekannt.

Wichtige Details der Einreichung:

  • Nathan besitzt derzeit keine Wertpapiere (abgeleitet oder nicht abgeleitet) wirtschaftlich im Unternehmen
  • Die Einreichung bestätigt seine Position als Direktor, weist jedoch keine weiteren Rollen wie Offizier oder 10%-Eigentümer aus
  • Dies ist eine individuelle Einreichung, keine gemeinsame oder Gruppenmeldung
  • Die Geschäftsadresse lautet 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

Das Formular 3 ist eine standardmäßige regulatorische Anforderung für neue Direktoren gemäß Abschnitt 16(a) des Securities Exchange Act von 1934 und legt eine Basis für zukünftige Eigentumsberichte fest.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
NATHAN GILBERT E

(Last) (First) (Middle)
C/O ACCELERATE DIAGNOSTICS, INC.
3950 S. COUNTRY CLUB ROAD, SUITE 470

(Street)
TUCSON AZ 85714

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/10/2025
3. Issuer Name and Ticker or Trading Symbol
Accelerate Diagnostics, Inc [ AXDX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Gilbert Nathan 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the new director appointed to AXDX's board in April 2025?

Gilbert E. Nathan was appointed as a Director of Accelerate Diagnostics (AXDX) effective April 10, 2025, as indicated in the Form 3 filing.

Does Gilbert Nathan own any shares of AXDX stock upon appointment?

According to the Form 3 filing, Gilbert Nathan owns no securities of AXDX beneficially, either directly or indirectly, at the time of his appointment as Director.

What is Gilbert Nathan's role at AXDX as of April 2025?

Gilbert Nathan serves as a Director at Accelerate Diagnostics (AXDX). The Form 3 indicates he is not an officer or 10% owner, but solely holds the position of Director.

When did Gilbert Nathan file his initial Form 3 for AXDX?

Gilbert Nathan filed his Form 3 (Initial Statement of Beneficial Ownership) on June 25, 2025, as evidenced by the signature date on the filing, reporting his beneficial ownership following his appointment as Director on April 10, 2025.
Accelerate Diagnostics Inc

NASDAQ:AXDX

AXDX Rankings

AXDX Latest News

AXDX Stock Data

3.49M
15.63M
37.53%
18.91%
1.76%
Medical Devices
Laboratory Analytical Instruments
Link
United States
TUCSON